Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2007-02-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1152/AJPHEART.00173.2006PMID 16980338
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rescue of Monocrotaline-Induced Pulmonary Arterial Hypertension Using Bone Marrow–Derived Endothelial-Like Progenitor Cells: Efficacy of Combined Cell and eNOS Gene Therapy in Established Disease

  2005influential reference
• Transplanted human embryonic stem cells as biological 'catalysts' for tissue repair and regeneration.

  2005cited by this paper
• Financial incentives for cadaveric organ donation.

  2004cited by this paper
• Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms

  2004influential reference
• Adrenomedullin in the treatment of pulmonary hypertension.

  2004cited by this paper
• Engineering Ex Vivo–Expanded Marrow Stromal Cells to Secrete Calcitonin Gene–Related Peptide Using Adenoviral Vector

  2004influential reference
• Lung transplantation for end-stage primary pulmonary hypertension.

  2004cited by this paper
• Transplantation of Endothelial Progenitor Cells into the Lung to Alleviate Pulmonary Hypertension in Dogs

  2004influential reference
• Mechanical stress promotes the expression of smooth muscle-like properties in marrow stromal cells.

  2004cited by this paper
• Disruption of Endothelial-Cell Caveolin-1&agr;/Raft Scaffolding During Development of Monocrotaline-Induced Pulmonary Hypertension

  2004influential reference
• Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood.

  2003cited by this paper
• Adenoviral gene transfer of eNOS: high-level expression in ex vivo expanded marrow stromal cells.

  2003influential reference
• Primary pulmonary hypertension: survival benefits of therapy with prostacyclin analogs and transplantation.

  2003cited by this paper
• In Vivo Gene Transfer of the O2-Sensitive Potassium Channel Kv1.5 Reduces Pulmonary Hypertension and Restores Hypoxic Pulmonary Vasoconstriction in Chronically Hypoxic Rats

  2003cited by this paper
• Hybrid Cell–Gene Therapy for Pulmonary Hypertension Based on Phagocytosing Action of Endothelial Progenitor Cells

  2003influential reference
• Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects

  2003cited by this paper
• Role of COX-1 and -2 in prostanoid generation and modulation of angiotensin II responses.

  2003cited by this paper
• Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epithelium.

  2002influential reference
• Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion

  2002cited by this paper
• Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice

  2002cited by this paper
• Changing potency by spontaneous fusion

  2002cited by this paper
• Cell-Based Gene Transfer of Vascular Endothelial Growth Factor Attenuates Monocrotaline-Induced Pulmonary Hypertension

  2001influential reference
• Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell.

  2001cited by this paper
• Bone marrow-derived cells as progenitors of lung alveolar epithelium.

  2001cited by this paper
• Alterations of endothelium and smooth muscle function in monocrotaline-induced pulmonary hypertensive arteries.

  2000cited by this paper
• Gene Transfer of Human Prostacyclin Synthase Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats

  2000cited by this paper
• Adrenomedullin in the treatment of pulmonary hypertension

  2000influential reference
• A COMPARISON OF CONTINUOUS INTRAVENOUS EPOPROSTENOL ( PROSTACYCLIN ) WITH CONVENTIONAL THERAPY FOR PRIMARY PULMONARY HYPERTENSION

  2000cited by this paper
• Cell-based gene transfer to the pulmonary vasculature: Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension.

  1999influential reference
• Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo. Effect on agonist-induced and flow-mediated vascular responses.

  1999cited by this paper
• EndothelinA receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension.

  1998cited by this paper
• Primary pulmonary hypertension.

  1998cited by this paper
• Novel catheterization technique for the in vivo measurement of pulmonary vascular responses in rats.

  1998influential reference
• Novel catheterization technique for the in vivo measurement of pulmonary vascular responses in rats.

  1998cited by this paper
• Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

  1998cited by this paper
• Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues

  1997cited by this paper
• Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension.

  1996cited by this paper
• A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.

  1996cited by this paper
• Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.

  1995influential reference
• Responses to pressure and vasoactive agents by isolated pulmonary arteries from monocrotaline-treated rats.

  1994cited by this paper
• Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

  1991cited by this paper
• Tone-dependent responses to acetylcholine in the feline pulmonary vascular bed.

  1988cited by this paper
• PRIMARY PULMONARY HYPERTENSION: A NATIONAL PROSPECTIVE STUDY

  1987cited by this paper
• Primary pulmonary hypertension.

  1987cited by this paper
• PRIMARY PULMONARY HYPERTENSION

  1957cited by this paper
• Primary pulmonary hypertension. I. Clinical and hemodynamic study.

  1951cited by this paper
• Changing potency by spontaneous fusion

  year unknowncited by this paper
• Chronic Hypoxia-induced Pulmonary Hypertension in the Mouse Related Peptide to the Lung Attenuates − in Vivo Gene Transfer of Prepro-calcitonin Gene in Vivo Gene Transfer of Prepro-calcitonin Gene–related Peptide to the Lung Attenuates Chronic Hypoxia-induced Pulmonary Hypertension in the Mouse

  year unknowncited by this paper

• Mesenchymal Stem Cell–Conditioned Media Modulate HUVEC Response to H2O2: Impact on Gene Expression and Potential for Atherosclerosis Intervention

  2024cites this paper
• Unraveling the pathogenesis of viral-induced pulmonary arterial hypertension: Possible new therapeutic avenues with mesenchymal stromal cells and their derivatives.

  2024cites this paper
• Extrapulmonary manifestations of pulmonary arterial hypertension

  2024cites this paper
• Tadalafil Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells-Derived Exosomes in Pulmonary Hypertension by Upregulating miR-29a-3p

  2024cites this paper
• Mesenchymal stromal cell therapy for chronic lung diseases: experimental and clinical evidence

  2023cites this paper
• Stem cell therapy in pulmonary hypertension: current practice and future opportunities

  2023cites this paper
• Mechanisms of Pulmonary Vascular Dysfunction in Pulmonary Hypertension and Implications for Novel Therapies.

  2022cites this paper
• MSC Transplantation Attenuates Inflammation, Prevents Endothelial Damage and Enhances the Angiogenic Potency of Endogenous MSCs in a Model of Pulmonary Arterial Hypertension

  2022cites this paper
• Mesenchymal Stem Cell-Derived Nanovesicles as a Credible Agent for Therapy of Pulmonary Hypertension.

  2022cites this paper
• The universal stem cell

  2022cites this paper
• Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension

  2021influential citation
• Comparison of quantitative and qualitative scoring approaches for radiation-induced pulmonary fibrosis as applied to a preliminary investigation into the efficacy of mesenchymal stem cell delivery methods in a rat model

  2021cites this paper
• Therapeutic effects of stem cells in different body systems, a novel method that is yet to gain trust: A comprehensive review

  2021cites this paper
• PTBP1 Targets ILK to Regulate the Hypoxia-Induced Phenotypic Transformation of Pulmonary Artery Smooth Muscle Cells

  2021cites this paper
• Diez años de investigación en vesículas extracelulares de células mesenquimales para tratar enfermedades pulmonares

  2021cites this paper
• After Effects of COVID-19 and Repair of Lungs

  2021cites this paper
• The potential of mesenchymal stem cell therapy for chronic lung disease

  2020cites this paper
• Therapeutic Treatment with Abdominal Adipose Mesenchymal Cells Does Not Prevent Elastase-Induced Emphysema in Rats.

  2020cites this paper
• Stem/Progenitor Cells and Pulmonary Arterial Hypertension.

  2020cites this paper
• CAR (CARSKNKDC) Peptide Modified ReNcell-Derived Extracellular Vesicles as a Novel Therapeutic Agent for Targeted Pulmonary Hypertension Therapy

  2020cites this paper
• Effects of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Future Perspectives

  2020cites this paper
• EMERGING ANTENATAL THERAPIES FOR CONGENITAL DIAPHRAGMATIC HERNIA-INDUCED PULMONARY HYPERTENSION IN PRECLINICAL MODELS

  2020cites this paper
• Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the EndMT.

  2020cites this paper
• Conditioned medium from M2b macrophages modulates the proliferation, migration, and apoptosis of pulmonary artery smooth muscle cells by deregulating the PI3K/Akt/FoxO3a pathway

  2020cites this paper
• Therapeutic efficacy of mesenchymal stromal cells and secretome in pulmonary arterial hypertension: a systematic review and meta-analysis.

  2019cites this paper
• Chapter 4 Nitric Oxide in Pathophysiology and Treatment of Pulmonary Hypertension

  2019cites this paper
• Mesenchymal stem/stromal cell therapy for pulmonary arterial hypertension: Comprehensive review of preclinical studies.

  2019cites this paper
• Title : THERAPEUTIC TREATMENT WITH MESENCHYMAL CELLS ISOLATED FROM ABDOMINAL ADIPOSE TISSUE DOES NOT PREVENT ELASTASE-INDUCED EMPHYSEMA IN THE RAT Short Title : The effect of Mesenchymal cells on COPD

  2019cites this paper
• Efficacy of stem cell therapy for pulmonary arterial hypertension: a systematic review and meta-analysis of preclinical studies

  2019cites this paper
• Paving the Road for Mesenchymal Stem Cell-Derived Exosome Therapy in Bronchopulmonary Dysplasia and Pulmonary Hypertension

  2019cites this paper
• Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia

  2019cites this paper
• Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review

  2019cites this paper
• NH4Cl treatment prevents doxorubicin-induced myocardial dysfunction in vivo.

  2019cites this paper
• Inhibition of miR-495 Improves Both Vascular Remodeling and Angiogenesis in Pulmonary Hypertension

  2019cites this paper
• Stem Cell Delivery Systems and Devices - Spraying

  2019cites this paper
• Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies

  2019cites this paper
• Mesenchymal Regulation of the Microvascular Niche in Chronic Lung Diseases.

  2019cites this paper
• Hemodynamic and Histopathologic Benefits of Early Treatment with Macitentan in a Rat Model of Pulmonary Arterial Hypertension

  2018cites this paper
• Stem cell therapy in chronic obstructive pulmonary disease. How far is it to the clinic?

  2018cites this paper
• Intratracheal Administration of Autologous Bone Marrow-Derived Cells Ameliorates Monocrotaline-Induced Pulmonary Vessel Remodeling and Lung Inflammation in Rats

  2018cites this paper
• Title Adipose-derived regenerative cell therapy inhibits the progression ofmonocrotaline-induced pulmonary hypertension in rats

  2018cites this paper
• Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?

  2018cites this paper
• Mesenchymal stem cells pretreated with melatonin ameliorate kidney functions in a rat model of diabetic nephropathy.

  2018cites this paper
• Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?

  2018cites this paper
• Therapeutic benefits of intravenous cardiosphere-derived cell therapy in rats with pulmonary hypertension

  2017cites this paper
• Regenerative Potential of Mesenchymal Stem Cells: Therapeutic Applications in Lung Disorders

  2017cites this paper
• Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension

  2017influential citation
• Novel Therapeutic Strategies for the Treatment of Pulmonary Arterial Hypertension

  2017cites this paper
• Combination treatment of adipose-derived stem cells and adiponectin attenuates pulmonary arterial hypertension in rats by inhibiting pulmonary arterial smooth muscle cell proliferation and regulating the AMPK/BMP/Smad pathway

  2017cites this paper
• Optimal Dose and Timing of Umbilical Stem Cells Treatment in Pulmonary Arterial Hypertensive Rats

  2017influential citation
• The use of mesenchymal stromal cells in treatment of lung disorders.

  2017cites this paper
• Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity

  2016cites this paper
• Human mesenchymal stem cells attenuate pulmonary hypertension induced by prenatal lipopolysaccharide treatment in rats

  2016cites this paper
• Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension

  2016cites this paper
• Fibroblast Growth Factor-10 (FGF-10) Mobilizes Lung-resident Mesenchymal Stem Cells and Protects Against Acute Lung Injury

  2016cites this paper
• Bone Marrow-derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension.

  2016cites this paper
• Lung Regeneration: Endogenous and Exogenous Stem Cell Mediated Therapeutic Approaches

  2016cites this paper
• Comparison between the Effect of CD34+ Stem Cells and Mesenchymal Stem Cells in Improving Pulmonary Fibrosis in Bleomycin Rat Model

  2016cites this paper
• The biology and potential clinical applications of mesenchymal stromal cells in diseases of the lung

  2016cites this paper
• The emerging role of microRNAs in hypoxia-induced pulmonary hypertension

  2016cites this paper
• Human umbilical cord derived mesenchymal stem cells suppress over-proliferation of pulmonary artery smooth muscle cells in a rat model of pulmonary hypertension

  2016cites this paper
• Nebivolol has a beneficial effect in monocrotaline-induced pulmonary hypertension.

  2016cites this paper
• Priming with ceramide-1 phosphate promotes the therapeutic effect of mesenchymal stem/stromal cells on pulmonary artery hypertension.

  2016cites this paper
• Mesenchymal stem cells transplantation improves functions of circulating endothelial progenitor cells in a rat model of pulmonary hypertension

  2016cites this paper
• Mesenchymal Stromal Cell-Based Therapies for Lung Disease

  2015cites this paper
• Exosomes in Mesenchymal Stem Cells, a New Therapeutic Strategy for Cardiovascular Diseases?

  2015cites this paper
• Priming Mesenchymal Stem Cells with Endothelial Growth Medium Boosts Stem Cell Therapy for Systemic Arterial Hypertension

  2015cites this paper
• Regenerative Medicine for Diseases of the Respiratory System

  2015cites this paper
• The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats

  2015cites this paper
• Successful Mitigation of Radiation Injuries in Mice using Mesenchymal Stem Cells Genetically Modified to Secrete Extracellular Superoxide Dismutase

  2015cites this paper
• Effect of Intratracheal Administration of Adipose-derived Stromal Cells on Bleomycin-induced Lung Injury in a Rat Model.

  2015cites this paper
• Mesenchymal stem cells suppress CaN/NFAT expression in the pulmonary arteries of rats with pulmonary hypertension

  2015cites this paper
• Emerging therapies and future directions in pulmonary arterial hypertension.

  2015cites this paper
• The Role of Stem Cells in Vascular Remodeling in CTEPH

  2015cites this paper
• Bone Marrow-derived Cells Contribute to Pathogenesis of Pulmonary Arterial Hypertension.

  2015cites this paper
• Challenges of Cell Therapy for Lung Diseases and Critical Illnesses

  2015cites this paper
• MicroRNAs and mesenchymal stem cells: hope for pulmonary hypertension

  2015cites this paper
• The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension

  2015influential citation
• Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats

  2015cites this paper
• Role of nitric oxide in pathophysiology and treatment of pulmonary hypertension.

  2014cites this paper
• The effect of PS-341 on pulmonary vascular remodeling in high blood flow-induced pulmonary hypertension.

  2014cites this paper
• Pathology, Pathobiology and Pathophysiology of Pulmonary Arterial Hypertension

  2014cites this paper
• Therapeutic effects of mesenchymal stem cell-derived microvesicles on pulmonary arterial hypertension in rats

  2014cites this paper
• MSC Microvesicles for the Treatment of Lung Disease: A New Paradigm for Cell-Free Therapy

  2014influential citation
• Activin-Directed Differentiation of Human Embryonic Stem Cells Differentially Modulates Alveolar Epithelial Wound Repair via Paracrine Mechanism

  2014cites this paper
• The effect of adipose derived stromal cells on oxidative stress level, lung emphysema and white blood cells of guinea pigs model of chronic obstructive pulmonary disease

  2014cites this paper
• Adipose-derived regenerative cell therapy inhibits the progression of monocrotaline-induced pulmonary hypertension in rats.

  2014cites this paper
• Novel and emerging therapies for pulmonary hypertension.

  2014cites this paper
• Lung stem and progenitor cells in tissue homeostasis and disease.

  2014cites this paper
• Tissue Engineering for the Respiratory Epithelium: Cell-Based Therapies for Treatment of Lung Disease

  2014cites this paper
• Intratracheal administration of cyclooxygenase-1-transduced adipose tissue-derived stem cells ameliorates monocrotaline-induced pulmonary hypertension in rats.

  2014cites this paper
• Paracrine regulation of fetal lung morphogenesis using human placenta-derived mesenchymal stromal cells.

  2014cites this paper
• Long-term research of stem cells in monocrotaline-induced pulmonary arterial hypertension

  2014cites this paper
• Hypertensive Rat Lungs Retain Hallmarks of Vascular Disease upon Decellularization but Support the Growth of Mesenchymal Stem Cells

  2014cites this paper
• Regenerative cell and tissue-based therapies for pulmonary arterial hypertension.

  2014cites this paper
• Vascular Repair and Regeneration as a Therapeutic Target for Pulmonary Arterial Hypertension

  2013cites this paper
• Dysfunctional resident lung mesenchymal stem cells contribute to pulmonary microvascular remodeling

  2013cites this paper
• Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension

  2013cites this paper
• Targeting smooth muscle microRNAs for therapeutic benefit in vascular disease.

  2013cites this paper
• GAPDH is critical for superior efficacy of female bone marrow-derived mesenchymal stem cells on pulmonary hypertension.

  2013cites this paper